You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Interferon beta-1a

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis Trial in Cairo (Blood sample collection)

Recruiting
  • Multiple Sclerosis
  • Blood sample collection
  • Cairo, Egypt
    Nasser Institute for Research and Treatment
Feb 21, 2023

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial

Not yet recruiting
  • Recurrent B Acute Lymphoblastic Leukemia
  • +5 more
  • Interferon Beta-1A
  • +10 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 6, 2023

Multiple Sclerosis Trial in Shreveport (Interferon beta 1a, oral doxycycline)

Completed
Has Results
  • Multiple Sclerosis
  • Interferon beta 1a, oral doxycycline
  • Shreveport, Louisiana
    LSU Health Sciences Center Shreveport
Oct 11, 2022

Covid19 Trial in United States (IFN beta-1a, Dexamethasone)

Terminated
Has Results
  • Covid19
  • Aurora, Colorado
  • +3 more
Oct 13, 2022

Healthy Subjects, Pharmacokinetics, Pharmacodynamics Trial in West Bend (Interferon beta-1a, Peginterferon beta-1a, Placebo)

Completed
  • Healthy Subjects
  • +2 more
  • Interferon beta-1a
  • +2 more
  • West Bend, Wisconsin
    Spaulding Clinical Research
Aug 16, 2021

Relapsing Remitting Multiple Sclerosis (RRMS) Trial in Tehran (Pegylated interferon beta-1a, Interferon Beta-1A Prefilled

Active, not recruiting
  • Relapsing Remitting Multiple Sclerosis (RRMS)
  • Pegylated interferon beta-1a
  • Interferon Beta-1A Prefilled Syringe
  • Tehran, Iran, Islamic Republic of
    Sina Hospital
Feb 5, 2022

Female Participants Exposed to Subcutaneous Peginterferon

Completed
  • Multiple Sclerosis
  • Multiple Sclerosis, Relapsing-Remitting
  • Interferon Beta Therapy
  • Göttingen, Germany
    Research Site
Nov 1, 2021

Multiple Sclerosis Trial (Diroximel Fumarate, Avonex, Tysabri)

Not yet recruiting
  • Multiple Sclerosis
  • Diroximel Fumarate
  • +3 more
  • (no location specified)
Dec 12, 2022

Learn About Interferon-beta Exposure of Pregnant Women During

Not yet recruiting
  • Multiple Sclerosis (MS)
  • Avonex (IFNβ-1-a, Biogen Netherlands B.V)
  • +5 more
  • Multiple Locations, Finland
  • +1 more
Sep 19, 2023

Multiple Sclerosis, Relapsing-Remitting Trial in Nizhny Novgorod (BCD-054 180 mcg, Avonex®, BCD-054 240 mcg)

Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • BCD-054 180 mcg
  • +3 more
  • Nizhny Novgorod, Russian Federation
    State Budgetary Healthcare Institution of Nizhny Novgorod region
Sep 6, 2021

Assess Pregnancy Outcomes in Women Exposed to Diroximel Fumarate

Recruiting
  • Multiple Sclerosis
  • Diroximel Fumarate
  • +8 more
  • Eden Prairie, Minnesota
    OptumInsight
Jan 9, 2023

Relapsing-remitting Multiple Sclerosis Trial in Rockland, Darmstadt (Evobrutinib, Avonex®, Avonex® matched Placebo)

Terminated
Has Results
  • Relapsing-remitting Multiple Sclerosis
  • Rockland, Massachusetts
  • +1 more
Jul 13, 2021

Multiple Sclerosis, Relapsing-Remitting Trial in Kocaeli (EK-12, INF beta-1a)

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Kocaeli, Turkey
    Kocaeli University, Faculty of Medicine, Department of Neurology
Jul 23, 2021

Relapsing-remitting Multiple Sclerosis Trial in Rockland, Darmstadt (Evobrutinib, Avonex®, Avonex® matched Placebo)

Terminated
Has Results
  • Relapsing-remitting Multiple Sclerosis
  • Rockland, Massachusetts
  • +1 more
Jul 13, 2021

Preventive Medicine, Multi Organ Failure Trial in Estonia, Finland, Lithuania (Interferon Beta-1A, Placebo)

Terminated
Has Results
  • Preventive Medicine
  • Multi Organ Failure
  • Interferon Beta-1A
  • Placebo
  • Tartu, Estonia
  • +8 more
Dec 22, 2020

Assess Adherence to Treatment for Patients With RMS (MAIN-MS)

Completed
  • Relapsing Multiple Sclerosis (RMS)
  • Rebif (Interferon beta-1a)
  • Alger, Algeria
  • +40 more
Mar 22, 2022

Interferon Beta-1a on Changes of Non-conventional MRI Measures

Completed
  • Multiple Sclerosis
  • Avonex® monotherapy (6.0 MIU administered i.m. each week)
  • Buffalo, New York
    The Jacobs Neurological Institute
Dec 23, 2020

Relapsing Multiple Sclerosis Trial in Worldwide (Interferon beta-1a, Ocrelizumab-matching , Ocrelizumab)

Active, not recruiting
Has Results
  • Relapsing Multiple Sclerosis
  • Interferon beta-1a
  • +3 more
  • Phoenix, Arizona
  • +140 more
Jan 2, 2023

Covid19 Trial in Kingston (Remdesivir, Acalabrutinib, Interferon beta-1a)

Not yet recruiting
  • Covid19
  • Kingston, Jamaica
    Univeristy of the West Indies
May 10, 2021

COPD (COPD) Trial in Manchester, Nottingham, Southampton (Interferon Beta-1A, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Interferon Beta-1A
  • Placebo
  • Belfast, United Kingdom
  • +15 more
Jan 3, 2023

Multiple Sclerosis Trial in Worldwide (Interferon beta-1a, Fingolimod, Placebo capsule)

Recruiting
Has Results
  • Multiple Sclerosis
  • Interferon beta-1a
  • +3 more
  • Birmingham, Alabama
  • +106 more
Jan 13, 2023

COVID-19 Trial in Tehran (Hydroxychloroquine, Lopinavir / Ritonavir, Interferon Beta-1A)

Completed
  • COVID-19
  • Tehran, Iran, Islamic Republic of
    Loghman Hakim Hospital, Shahid Beheshti University of Medical Sc
May 2, 2020

SARS-CoV Infection, Interferon, Covid19 Trial in Santiago (Peginterferon beta-1a)

Completed
  • SARS-CoV Infection
  • +2 more
  • Peginterferon beta-1a
  • Santiago, Chile
    Pontificia Universidad Católica de Chile
Sep 2, 2021

Relapsing Multiple Sclerosis Trial (Placebo, BIIB061, Interferon-beta1)

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Placebo
  • +3 more
  • (no location specified)
Mar 22, 2021

COVID-19 Trial in Tehran (Interferon Beta-1A, Lopinavir / Ritonavir, Single Dose of Hydroxychloroquine)

Unknown status
  • COVID-19
  • Interferon Beta-1A
  • +2 more
  • Tehran, Iran, Islamic Republic of
    Loghman Hakim Hospital, Shahid Beheshti University of Medical Sc
Apr 16, 2020